Renibus Therapeutics
PrivateLast Round
Series B
Sep 12, 2023
Total Funding Raised
$187M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Renibus Therapeutics is a clinical-stage biopharmaceutical company that develops products to prevent disease progression, improve outcomes, and protect against organ damage associated with cardio, renal, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renibus Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Renibus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 12, 2023 | ||||
| Series B | Jul 17, 2023 | ||||
| Debt | Aug 1, 2022 | ||||
| SAFE | Aug 1, 2022 | ||||
| Series A | Feb 15, 2022 |
Key People
Founding team and executive leadership
Renibus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Finance | Debt |
| Bios Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 98% MoM, reaching 3.7K.
- Mar 26, 2026
Attending the 25th Annual Needham Virtual Healthcare Conference April 13-16, 2026.
Renibus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Renibus Therapeutics's valuation, stock price, and market status.